BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 12847642)

  • 1. [Contrast medium-supported sonography of the liver--a challenge to German radiology].
    Albrecht T
    Rofo; 2003 Jul; 175(7):889-91. PubMed ID: 12847642
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients.
    von Herbay A; Westendorff J; Gregor M
    J Clin Ultrasound; 2010 Jan; 38(1):1-9. PubMed ID: 19790253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contrast-enhanced sonography of the liver].
    Uggowitzer MM; Gotschuli G; Reiter H; Petek B
    Radiologe; 2005 Jan; 45(1):24-33. PubMed ID: 15565382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New aspects in sonography of the liver].
    Hagara D; Schwarzenbach HR; Cerny A
    Praxis (Bern 1994); 2012 Sep; 101(18):1161-6. PubMed ID: 22945816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of hepatocellular carcinoma by contrast enhanced ultrasound: a novel technique.
    Paul SB; Jaganathan S; Hasan A; Dhingra R; Gamanagatti SR; Gupta AK; Acharya SK
    Trop Gastroenterol; 2010; 31(3):213-6. PubMed ID: 21560527
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatocellular carcinoma presenting as a wandering abdominal lump with atypical CEUS.
    Xu HS; Li SY; Liang X; Shou JD; Xu K; He YT
    Ultraschall Med; 2013 Aug; 34(4):388-90. PubMed ID: 23929380
    [No Abstract]   [Full Text] [Related]  

  • 9. The appropriate allocation of CEUS in the diagnostic algorithm of liver lesions: a debated issue.
    Bolondi L
    Ultraschall Med; 2013 Feb; 34(1):8-10. PubMed ID: 23335229
    [No Abstract]   [Full Text] [Related]  

  • 10. Focal liver processes: "better is the enemy of good": CEUS in the fast lane.
    Braun B
    Ultraschall Med; 2009 Aug; 30(4):329-32. PubMed ID: 19688667
    [No Abstract]   [Full Text] [Related]  

  • 11. Foreword to guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012.
    Greenbaum LD
    Ultraschall Med; 2013 Feb; 34(1):7. PubMed ID: 23335228
    [No Abstract]   [Full Text] [Related]  

  • 12. Emerging clinical applications for contrast-enhanced ultrasonography.
    Spinazzi A
    Eur Radiol; 2001; 11 Suppl 3():E7-12. PubMed ID: 11793047
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
    Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
    Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contrast-enhanced ultrasound for characterisation of focal liver lesions, practical advice].
    Fröhlich E; Jenssen C; Schuler A; Dietrich CF
    Z Gastroenterol; 2015 Sep; 53(9):1099-107. PubMed ID: 26367027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.
    Claudon M; Dietrich CF; Choi BI; Cosgrove DO; Kudo M; Nolsøe CP; Piscaglia F; Wilson SR; Barr RG; Chammas MC; Chaubal NG; Chen MH; Clevert DA; Correas JM; Ding H; Forsberg F; Fowlkes JB; Gibson RN; Goldberg BB; Lassau N; Leen EL; Mattrey RF; Moriyasu F; Solbiati L; Weskott HP; Xu HX
    Ultraschall Med; 2013 Feb; 34(1):11-29. PubMed ID: 23129518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Color doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist.
    Ernst H; Hahn EG; Balzer T; Schlief R; Heyder N
    J Clin Ultrasound; 1996 Jan; 24(1):31-5. PubMed ID: 8655665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contrast ultrasonography: value in diagnosis and characterisation of hepatic tumors].
    Aubé C; Lebigot J
    Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B63-70. PubMed ID: 12843939
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reader's letter concerning the article by H. Strunk et al. (Fortschr Röntgenstr 2005, 177:900-904). Erroneous diagnosis of liver metastasis as benign tumor in the contrast media aided "Low-MI-Real-Time" sonography with SonoVue].
    Schlottmann K
    Rofo; 2005 Dec; 177(12):1722-3; author reply 1723. PubMed ID: 16382508
    [No Abstract]   [Full Text] [Related]  

  • 19. [Characterization of hepatic tumors with contrast-enhanced ultrasound and digital grey-scale analysis].
    Lemke AJ; Chopra SS; Hengst SA; Brinkmann MJ; Steinmüller T; Felix R
    Rofo; 2004 Nov; 176(11):1607-16. PubMed ID: 15497079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between SonoVue enhancement in CEUS, HCC differentiation and HCC diameter: analysis of 130 patients with hepatocellular carcinoma (HCC).
    von Herbay A; Vogt C; Westendorff J; Häussinger D; Gregor M
    Ultraschall Med; 2009 Dec; 30(6):544-50. PubMed ID: 19998208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.